Tech Company Financing Transactions

Cedilla Therapeutics Funding Round

Boxer Capital, Casdin Capital and Eli Lilly and Company participated in a $57.6 million Series B venture round for Cedilla Therapeutics. The funding round closed on 10/14/2020.

Transaction Overview

Company Name
Cedilla Therapeutics
Announced On
10/14/2020
Transaction Type
Venture Equity
Amount
$57,600,000
Round
Series B
Investors

Boxer Capital (Lead Investor) (Dominik Naczynski)

Casdin Capital (Lead Investor) (Eli Casdin)

Eli Lilly and Company

Schroder Adveq

Third Rock Ventures

Proceeds Purpose
Proceeds from this financing will support ongoing efforts to build a broad portfolio of small molecule medicines, including the identification and preclinical development of Cedilla's first two product candidates.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
245 1st St. 3rd Floor
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
www.cedillatx.com
Email Address
[email protected]
Overview
Cedilla Therapeutics is discovering and exploiting unique insights into protein stability. Cedilla's integrated, multi-faceted approach has the potential to broaden the reach of small molecules by generating therapeutics that degrade protein targets as their primary mechanism of action.
Profile
Cedilla Therapeutics LinkedIn Company Profile
Social Media
Cedilla Therapeutics Company Twitter Account
Company News
Cedilla Therapeutics News
Facebook
Cedilla Therapeutics on Facebook
YouTube
Cedilla Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Alexandra Glucksmann
  Alexandra Glucksmann LinkedIn Profile  Alexandra Glucksmann Twitter Account  Alexandra Glucksmann News  Alexandra Glucksmann on Facebook
Chief Scientific Officer
Brian Jones
  Brian Jones LinkedIn Profile  Brian Jones Twitter Account  Brian Jones News  Brian Jones on Facebook
Vice President
Delphine Collin
  Delphine Collin LinkedIn Profile  Delphine Collin Twitter Account  Delphine Collin News  Delphine Collin on Facebook
Vice President
Josh Murtie
  Josh Murtie LinkedIn Profile  Josh Murtie Twitter Account  Josh Murtie News  Josh Murtie on Facebook
Vice President
Eric Schwartz
  Eric Schwartz LinkedIn Profile  Eric Schwartz Twitter Account  Eric Schwartz News  Eric Schwartz on Facebook
VP - Bus. Development
Véronique Riethuisen
  Véronique Riethuisen LinkedIn Profile  Véronique Riethuisen Twitter Account  Véronique Riethuisen News  Véronique Riethuisen on Facebook
VP - Finance
Christopher Lindblom
  Christopher Lindblom LinkedIn Profile  Christopher Lindblom Twitter Account  Christopher Lindblom News  Christopher Lindblom on Facebook
VP - Human Resources
Justin Birtz
  Justin Birtz LinkedIn Profile  Justin Birtz Twitter Account  Justin Birtz News  Justin Birtz on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/13/2020: GetSetUp venture capital transaction
Next: 10/14/2020: Genemod venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to record tech company VC transactions. All VC database entries on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.